failed trials

arrow miss target fail attempt try
Pharma

BMS details Krazati confirmatory fail in colorectal cancer

BMS has detailed a phase 3 flop for KRAS inhibitor Krazati's smaller-opportunity accelerated FDA approval in colorectal cancer.
Fraiser Kansteiner Jul 7, 2026 10:46am
Brinsupri

Insmed terminates development of Brinsupri in another indication

Apr 8, 2026 7:57am
layoffs cuts workforce reduction chairs boxes fired
Favicon Fierce Biotech

Biopharma layoffs maintain slowdown in Q1

Apr 1, 2026 8:42am
Brinsupri

Insmed's Brinsupri comes up short in rhinosinusitis trial

Dec 18, 2025 11:27am
Graphic of arrows missing the target

After trial failure, Acadia scraps Prader-Willi candidate

Sep 24, 2025 3:29pm
Garbage truck picking up trash on suburban street
Favicon Fierce Biotech

Biohaven trashes troriluzole in OCD after ph. 3 fail

Aug 12, 2025 2:06pm